dyspepsia
DYSPEPSIA

Dyspepsia is having any one of the following: Disturbing postprandial fullness, early satiation, epigastric pain and/or burning felt predominantly in the upper abdomen.

It is considered a symptom complex rather than a specific diagnosis.

Acid suppression is the recommended initial therapy.

Dyspepsia Management

Specialist Referral

  • Specialist investigation is necessary for patients ≥60 years (younger in areas with high prevalence of gastric cancer), patients with alarm symptoms, patients who did not respond to empiric therapy and have persistent symptoms, and for further evaluation of an alternate diagnosis  

Endoscopy

  • Upper GI endoscopy is the investigation of choice when further evaluation is warranted
  • Endoscopy allows a clinician to view the GIT and, if necessary, perform diagnostic and therapeutic procedures, eg biopsy
  • Routine endoscopic investigation of patients <60 years old, presenting with dyspepsia and with or without alarm signs, is not necessary; consideration for endoscopy should be on a case-by-case basis per physician’s clinical judgment  
  • Should be reserved for patients who have little or no response to therapy after 7-10 days or for patients whose symptoms have not resolved after 4-8 weeks
    • If upper GI endoscopy is unremarkable, patients with persistent symptoms or alarm features should be evaluated further for other diagnosis
  • Depending on local protocol: For patients ≥60 years (younger in areas with high prevalence of gastric cancer), consider endoscopy when symptoms persist despite H pylori testing/treatment and acid suppression therapy, and when patient has one or more of:
    • Previous gastric ulcer or surgery
    • Continuing need for NSAID treatment
    • Raised risk of gastric cancer
    • Anxiety about cancer
  • Patients undergoing endoscopy should be free from medication with either a PPI or H2RA for a minimum of 2 weeks

Follow Up

  • Offer low-dose PPI or H2RA treatment with limited number of prescriptions or stopping treatment
    • Dyspepsia is a remitting and relapsing disease and continuous medication is not necessary after eradication of symptoms unless there is an underlying condition requiring treatment
  • May consider treatment with antacids when necessary
  • Continue to avoid known precipitants of dyspepsia including smoking, alcohol, coffee, chocolate, fatty foods and being overweight, and to adhere to lifestyle modifications
  • Monitor for appearance of alarm signs and symptoms
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, 4 days ago
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.